A woman in Washington state has become the fourth person to die from blood-clot complications after getting the Johnson & Johnson one-shot vaccine, according to health officials. This is very rare.

Nearly 450,000 New Jersey residents received the one-shot vaccine. Health officials continue to say the benefits of the vaccine outweigh the risks.

The woman who lost her life was in her late 30s, was vaccinated on Aug. 26 and died on Sept. 7 from a syndrome known as TTS -- a rare and potentially deadly clotting event that has been linked with the Johnson & Johnson vaccine.

Earlier this year, the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration recommended a pause in the use of the one-shot vaccine after a small number of reports of blood clots. 

Meanwhile, the company is asking the FDA for emergency authorization for its booster shot for people older than 18. It has shown to be 94% effective against symptomatic COVID-19 and offers 100% protection against severe illness.

An FDA committee will be meeting next Thursday and Friday to discuss authorizing the booster shot, as well as Moderna’s booster.